Aberrant gene expression of mTOR pathway alters cell growth and apoptosis in many cancer types such as prostate cancer, lung cancer, acute myelogenous leukemia, hepatocellular carcinoma, gastric cancer[27]–[31] and breast cancer. Here, MTOR is linked to hepatocellular carcinoma.